Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECNIDAZOLE vs SECUKINUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SECNIDAZOLE vs SECUKINUMAB: Safety Overview

Metric SECNIDAZOLE SECUKINUMAB
Total FAERS Reports 245 151,223
Deaths Reported 1 6,855
Death Rate 0.4% 4.5%
Hospitalizations 10 19,098
Average Patient Age 40.4 yrs 52.3 yrs
% Female Patients 95.6% 61.9%
FDA Approval Date Sep 15, 2017 N/A
Manufacturer Evofem Inc. Novartis Pharmaceuticals Corporation
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription